Rockwell Medical (NASDAQ: RMTI) has announced the appointment of Joe Dawson to its board of directors (BOD), and the resignation of Andrea Heslin Smiley from its BOD.
Mr. Dawson brings more than 25 years of experience in the renal care and cardiovascular markets to Rockwell. Most recently, he served as president of the North America division at Nipro Medical. Overseeing one of the largest global medical device manufacturer’s U.S. operations, Mr. Dawson’s leadership included strategic P&L responsibility, operational oversight, and direct accountability for compliance in highly regulated therapeutic categories including dialysis, vascular access, and infusion technologies.
In a statement, Robert S. Radie, chairman of Rockwell’s BOD, commented, “We are pleased to welcome Joe to Rockwell Medical’s BOD. Joe is a seasoned executive who has extensive operational experience, a strong network in the renal care space, and deep domain expertise in building and scaling commercial organizations. Additionally, on behalf of the company and its BOD, I would like to thank Andi for her five years of service and wish her continued success in her future ventures.”
